Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomeNews & EventsEvents
to the archive
+49 531 6181-1404
+49 531 6181-1499
The Federal Budget Committee has assured the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) funding of 47 million euros for the further expansion of the institute. Together with funds from the state of Saarland, the HIPS will receive a total of 70 million euros until 2025. The additional funds will go towards an extension building and further research groups…
Bacteria of the species Staphylococcus aureus are among the most common pathogens associated with hospital-acquired pneumonia worldwide. Multi-resistant strains of this pathogen have spread worldwide and constitute a major threat for health care, especially in countries with high antibiotic use. Hospital-acquired bacterial pneumonia has a high mortality rate of over 20 percent even…
Its metabolism and the structure of its cellular membrane render the hospital germ Pseudomonas aeruginosa resistant against several antibiotics. P. aeruginosa is responsible for around ten percent of all hospital infections, making it one of the most common multi-resistant germs. The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) now made an important step in the fight against…